Intracellular vesicle transport defects can induce retinal degeneration and photoreceptor cell death, but the molecular connections between these processes remains poorly understood. Reporting in Developmental Cell, Nishiwaki et al. (2013) suggest that a vesicle fusion cis-SNARE complex component translates vesicular transport defects into photoreceptor cell apoptosis.
To date, almost 200 distinct genes have been associated with hereditary blinding disorders (RetNet: https://sph.uth.edu/ retnet/disease.htm), which are currently not treatable. Despite the diversity of gene defects that cause visual impairment or legal blindness, the final, unifying event of the disease-causing pathophysiologic processes is the death of retinal neurons. A significant proportion (1/4) of retinal degenerations is related to defective intracellular transport in photoreceptor cells, and cargo misrouting accompanies photoreceptor degeneration as a hallmark of disease (e.g., Lopes et al., 2010) . Vertebrate photoreceptors are highly polarized elongated sensory neurons consisting of morphologically and functionally distinct cellular compartments. During photoreceptor maturation and maintenance, de novo biosynthesis occurs in organelles located in the inner segment, from which they are vectorially transported to either one of the two poles, the synapse or the photosensitive outer segment membranes. Disturbance of these efficient transport and targeting systems by defects in components of molecular transport machines or regulation modules leads to cargo misrouting, which finally triggers photoreceptor cell death and retinal degeneration. Over the last decade, photoreceptor cell biologists have gathered important insights into both the mechanisms of intracellular vesicle transport and photoreceptor cell death underlying retinal degenerations. Photoreceptor cell death mechanisms in inherited retinal degenerations can occur through either nonapoptotic pathways or apoptotic pathways (Portera-Cailliau et al., 1994; Sancho-Pelluz et al., 2008). However, the molecular connection between the defective cellular machineries and the cell death pathways remained unknown.
The SNARE system-the intracellular cargo and targeting system-ensures that vesicles are correctly directed to the target compartment (Jahn and Scheller, 2006) . At the target membrane vesicle, v-SNAREs bind to target membrane resident t-SNARE proteins to assemble the trans-SNARE membrane fusion complex. Subsequent to membrane fusion and vesicle cargo delivery, this complex rearranges into the cis-SNARE complex state.
Characterizing the retinal degeneration zebrafish coa mutant, Nishiwaki and colleagues (2013) now identify b-snap1 as the causative gene provoking BNip1-dependent photoreceptor apoptosis. The soluble N-ethylmaleimide-sensitive factor (NSF) attachment factor b-SNAP recruits the ATPase NSF for disassembling the cis-SNARE complex to introduce SNARE recycling for another cycle of vesicle targeting. Nishiwaki and colleagues (2013) demonstrate that the absence of b-SNAP inhibits disassembling of the endoplasmic reticulum (ER) resident syntaxin-18 cis-SNARE complex, thereby compromising the recycling of SNAREs and consequently arresting intracellular vesicular transport. In photoreceptor cells, this halting of vesicle transport has severe calamitous impacts on the maturation, as well as on the maintenance, of mature photoreceptor cells.
Analysis of knockdowns by morpholino antisense oligonucleotides to syntaxin-18 SNARE complex components provides strong evidence that apoptosis in photoreceptor cells is induced by the syntaxin-18 cis-SNARE complex, which activates Bax-dependent apoptosis via the BH3-only protein BNip1. BH3-only proteins balance the apoptotic activity of proteins from the Bcl2 family. The ERspecific BNip1 is bifunctional. First, as a t-SNARE component of the syntaxin-18 SNARE complex, it regulates the retrograde vesicle transport from the Golgi apparatus to the ER. Second, by binding to the antiapoptotic Bcl2 and Bcl-XL proteins, BNip1 modulates apoptosis by releasing the proapoptotic Bax protein.
In elegant analyses exploiting the advantages of the zebrafish model system in combination with skillful molecular genetics, cell biology, and biochemical tools, Nishiwaki and coworkers (2013) affirm this dual role of BNip1. Based on their data set, they provide a model suggesting that the proapoptotic activity of BNip1 depends on the accessibility of its BH3 domain to interact with Bcl2. In the acceptor SNARE complex, BNip1's coiled-coil domain suppresses the proapoptotic activity of the BNip1 by reducing the affinity of its BH3 domain to Bcl2. SNAP/NSF-mediated disassembly of the syntaxin-18 cis-SNARE complex triggers a conformational change in BNip1, which enables the BH3 domain to interact with Bcl2. BNip1-Bcl2 interaction subsequently activates Bax, initializing the mitochondria-dependent apoptosis pathway (Tait and Green, 2010) .
Nishiwaki and coworkers (2013) propose that the level of the syntaxin-18 cis-SNARE complex on the ER membrane is crucial for the decision as to whether photoreceptor cells survive or undergo apoptosis. Defects in the SNAP/NSFmediated cis-SNARE disassembly result in the accumulation of the syntaxin-18 cis-SNARE complex. This thereby reduces the recycling of the SNAREs and consequently inhibits new vesicle fusion and syntaxin-18 SNARE complex formation. The authors suggest that syntaxin-18 cis-SNARE complex functions as a quality control module that monitors the availability of SNAP during photoreceptor morphogenesis.
In conclusion, the present article elucidates a missing link in the pathophysiology between transport defects and apoptosis in photoreceptor cells. Now the question that remains to be answered is whether these findings depicted on maturing photoreceptor cells can be transferred to conditions of the frequent transport defects in mature cells observed in hereditary retinal disorders.
Nevertheless, further deciphering of the molecular interplay between the machineries of vesicular transport and apoptosis in photoreceptor cells should reveal novel targets for future treatments and potential cures for the sensoneuronal diseases (Mockel et al., 2012) such as Retinitis pigmentosa and other disorders induced by defects in molecular transport.
